Informationen:
Fehler:
ID
31673
Beschreibung
Phase II Study of ASP3550 in Patients With Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00568516
Link
https://clinicaltrials.gov/show/NCT00568516
Stichworte
Versionen (1)
- 19.09.18 19.09.18 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
19. September 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Prostatic Neoplasms NCT00568516
Eligibility Prostatic Neoplasms NCT00568516
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Prostatic Neoplasms NCT00568516
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Adenocarcinoma of prostate TNM clinical staging
Item
is a male patient with histologically proven prostate cancer (adenocarcinoma) of all stages
boolean
C0007112 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,2])
Indication Hormone Therapy | Raised prostate specific antigen Post Prostatectomy Curative | Raised prostate specific antigen Post Therapeutic radiology procedure Curative
Item
is a patient in whom endocrine treatment is indicated. patients with rising serum psa after having prostatectomy or radiotherapy performed with curative intention may be included
boolean
C3146298 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
C0178415 (UMLS CUI [2,1])
C0687676 (UMLS CUI [2,2])
C0033573 (UMLS CUI [2,3])
C1276305 (UMLS CUI [2,4])
C0178415 (UMLS CUI [3,1])
C0687676 (UMLS CUI [3,2])
C1522449 (UMLS CUI [3,3])
C1276305 (UMLS CUI [3,4])
C0279025 (UMLS CUI [1,2])
C0178415 (UMLS CUI [2,1])
C0687676 (UMLS CUI [2,2])
C0033573 (UMLS CUI [2,3])
C1276305 (UMLS CUI [2,4])
C0178415 (UMLS CUI [3,1])
C0687676 (UMLS CUI [3,2])
C1522449 (UMLS CUI [3,3])
C1276305 (UMLS CUI [3,4])
Serum testosterone measurement
Item
has a serum testosterone level above 1.5 ng/ml at screening
boolean
C0428413 (UMLS CUI [1])
ECOG performance status
Item
has an ecog (eastern co-operative oncology group) p.s. (performance status) score of 0 to 2
boolean
C1520224 (UMLS CUI [1])
Hormone Therapy Prostate carcinoma
Item
previous or present endocrine treatment for prostate cancer. however, patients who have undergone neoadjuvant/adjuvant endocrine therapy for a maximal duration of 6 months and in whom prostatectomy or radiotherapy was terminated at least 6 months preceding screening visit may be included
boolean
C0279025 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,2])
5-alpha Reductase Inhibitors
Item
is being treated with a 5α-reductase inhibitor
boolean
C2936788 (UMLS CUI [1])
Patient Appropriate Curative treatment | Patient Appropriate Radical prostatectomy | Patient Appropriate Therapeutic radiology procedure
Item
is a candidate for curative therapy, i.e., radical prostatectomy or radiotherapy within 12 months
boolean
C0030705 (UMLS CUI [1,1])
C1548787 (UMLS CUI [1,2])
C1273390 (UMLS CUI [1,3])
C0030705 (UMLS CUI [2,1])
C1548787 (UMLS CUI [2,2])
C0194810 (UMLS CUI [2,3])
C0030705 (UMLS CUI [3,1])
C1548787 (UMLS CUI [3,2])
C1522449 (UMLS CUI [3,3])
C1548787 (UMLS CUI [1,2])
C1273390 (UMLS CUI [1,3])
C0030705 (UMLS CUI [2,1])
C1548787 (UMLS CUI [2,2])
C0194810 (UMLS CUI [2,3])
C0030705 (UMLS CUI [3,1])
C1548787 (UMLS CUI [3,2])
C1522449 (UMLS CUI [3,3])
Severe asthma | Patient need for Inhaled steroids Daily | Anaphylaxis | Urticaria Severe | Angioedema
Item
has concurrent or a history of severe asthma (defined as a need for daily treatment with inhalation steroids), anaphylactic reactions, severe urticaria and angioedema
boolean
C0581126 (UMLS CUI [1])
C0686904 (UMLS CUI [2,1])
C2065041 (UMLS CUI [2,2])
C0332173 (UMLS CUI [2,3])
C0002792 (UMLS CUI [3])
C0042109 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C0002994 (UMLS CUI [5])
C0686904 (UMLS CUI [2,1])
C2065041 (UMLS CUI [2,2])
C0332173 (UMLS CUI [2,3])
C0002792 (UMLS CUI [3])
C0042109 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C0002994 (UMLS CUI [5])